Cardiovascular toxicity of nicotine: Implications for electronic cigarette use.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing pharmacology and literature on nicotine toxicity without systematic review methodology.
PubMed 27079891 · doi:10.1016/j.tcm.2016.03.001
What was done
The author reviewed evidence on the cardiovascular pharmacology and toxicity of nicotine, drawing on studies of nicotine replacement therapies, smokeless tobacco, and electronic cigarettes to assess the cardiovascular risks of non-combustible nicotine delivery.
What was found
The abstract reports no quantitative data or effect sizes. It qualitatively reports that nicotine without tobacco combustion products carries a low cardiovascular risk compared to cigarette smoking. However, risks remain a concern for individuals with pre-existing cardiovascular disease. In healthy users, electronic cigarettes appear to carry low cardiovascular risk over short-term use.
Why it matters
Understanding the isolated cardiovascular toxicity of nicotine helps frame the relative risk of electronic cigarettes compared to combustible tobacco products for public health policy and clinical guidance.
Limits
The abstract describes a narrative review without systematic search parameters, quantitative meta-analysis, or sample size reporting. Long-term cardiovascular outcomes of electronic cigarette use were not evaluated, and conclusions for electronic cigarettes rely heavily on extrapolation from other non-combustible nicotine sources.
Cited by
- supports Nicotine acts as a vasoconstrictor and raises blood pressure.